About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
CLSN - Celsion Corporation| Previous Close | $0.58 | Open | $0.58 |
| Volume | 609.7K | Market Cap | 20.79M |
| Yield | Last Dividend |
| Brokerages Expect Celsion Co. (NASDAQ:CL... | 10/20/20 |
| Wall Street brokerages expect Celsion Co. (NASDAQ:CLSN) to report $130,000.00 in sales for the current quarter, according to Zacks Investment Research... | |
| Celsion Corporation to Hold Second Quart... | 08/07/20 |
| LAWRENCEVILLE, N.J, Aug. 07, 2020 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) announced today that the Company will host a conference call ... | |
| Celsion among healthcare gainers; Aurini... | 07/23/20 |
| Gainers: Milestone Pharmaceuticals MIST +137%. CymaBay Therapeutics CBAY +34%. Entera Bio ENTX +31%. Celsion (NASDAQ:CLSN) +27%. AMAG Pharmaceuticals ... | |
| Celsion (CLSN) Stock Loses a Wall Street... | 07/17/20 |
| Stocks go up, stocks go down, you can???t explain that??? Or maybe you can, if the stock happen to be a biotech that just ??? The post Celsion (CLSN) ... | |
| Vaxart and Benefytt Technologies among h... | 07/13/20 |
| Gainers: Equillium EQ +155%. NovaBay Pharmaceuticals NBY +50%. Benefytt Technologies BFYT +38%. Vaxart (NASDAQ:VXRT) +31%. BiondVax Pharmaceuticals (N... | |
| Celsion Corporation Announces Closing of... | 06/24/20 |
| Lawrenceville, NJ, June 24, 2020 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced the??? | |
| Thinking about buying stock in Salem Med... | 06/19/20 |
| NEW YORK, June 19, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SALM, DVAX, CLSN, HTZ, and MGM. To see how InvestorsOb... | |
| Thinking about buying stock in Celsion C... | 06/17/20 |
| NEW YORK, June 17, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CLSN, WTER, SALM, OCUL, and DAL. To see how InvestorsO... | |
| Earnings Scheduled For May 15, 2020 | 05/15/20 |
| Companies Reporting Before The Bell V.F. Corporation (NYSE: VFC ) is projected to report quarterly earnings at $0.13 per share on revenue of $2.31 bil... | |
| Will Celsion (CLSN) Report Negative Q2 E... | 08/06/19 |
| Celsion (CLSN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with t... | |
| Celsion Approaches Drug Trial Binary | 05/29/19 |
| No summary available. | |
| Celsion Corporation (CLSN) CEO Michael T... | 05/15/19 |
| No summary available. | |
| Celsion net loss improves in Q1 | 05/15/19 |
| No summary available. | |
| Celsion beats by $0.13, revenue in-line | 05/15/19 |
| No summary available. | |
| Is Celsion (CLSN) Stock Outpacing Its Me... | 05/13/19 |
| Is (CLSN) Outperforming Other Medical Stocks This Year? | |
| Will Celsion (CLSN) Report Negative Earn... | 05/08/19 |
| Celsion (CLSN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with t... | |
| Celsion (CLSN) Dips More Than Broader Ma... | 05/07/19 |
| In the latest trading session, Celsion (CLSN) closed at $2.19, marking a -1.79% move from the previous day. | |
| Celsion (CLSN) Flat As Market Sinks: Wha... | 05/01/19 |
| Celsion (CLSN) closed at $2.20 in the latest trading session, marking no change from the prior day. | |
| Is Celsion (CLSN) Outperforming Other Me... | 04/26/19 |
| Is (CLSN) Outperforming Other Medical Stocks This Year? | |
| Celsion nabs new patent for Thermodox in... | 04/17/19 |
| No summary available. | |
| Celsion beats by $0.65, revenue in-line | 03/29/19 |
| No summary available. | |
| Celsion Corporation (CLSN) To Present At... | 03/20/19 |
| No summary available. | |
| Momentum Strategies That Continue To Dom... | 01/17/19 |
| No summary available. | |
| Momentum Strategies That Continue To Dom... | 01/17/19 |
| No summary available. | |
| Date | 2020-08-14 (AMC) | Est. (EPS/Rev.) | ($0.14)/ 80K |
| Actual (EPS/Rev.) | $-0.18/ $125.00 K | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Option Superstars | James Catzen | 75.00 % | Subscribe |
| Mojo Day Trading | ProTrader Mike | 46.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
